PBYI Insider Trading

Insider Ownership Percentage: 23.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $512,704.29

Puma Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at Puma Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Puma Biotechnology Share Price & Price History

Current Price: $2.86
Price Change: Price Decrease of -0.05 (-1.72%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for PBYI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Puma Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2025Alan H. AuerbachCEOSell33,841$3.15$106,599.157,029,674View SEC Filing Icon  
1/2/2025Jeffrey Jerome LudwigInsiderSell9,437$3.15$29,726.55108,951View SEC Filing Icon  
8/12/2024Michael Patrick MillerDirectorSell23,358$3.49$81,519.4247,000View SEC Filing Icon  
7/17/2024Alan H. AuerbachCEOSell21,920$3.70$81,104.007,063,515View SEC Filing Icon  
7/17/2024Jeffrey Jerome LudwigInsiderSell2,598$3.70$9,612.60118,388View SEC Filing Icon  
7/17/2024Maximo F. NouguesCFOSell4,156$3.70$15,377.20162,522View SEC Filing Icon  
7/2/2024Alan H. AuerbachCEOSell18,885$3.27$61,753.957,085,435View SEC Filing Icon  
7/2/2024Jeffrey Jerome LudwigInsiderSell6,051$3.27$19,786.77120,986View SEC Filing Icon  
7/2/2024Maximo F. NouguesCFOSell5,295$3.27$17,314.65166,678View SEC Filing Icon  
6/13/2024Troy Edward WilsonDirectorSell27,000$3.33$89,910.00350View SEC Filing Icon  
1/3/2024Alan H. AuerbachCEOSell41,396$4.49$185,868.046,936,947View SEC Filing Icon  
1/3/2024Alvin F. WongInsiderSell7,733$4.49$34,721.1798,214View SEC Filing Icon  
1/3/2024Maximo F. NouguesCFOSell15,682$4.49$70,412.18128,666View SEC Filing Icon  
11/7/2023Michael Patrick MillerDirectorSell25,000$2.83$70,750.0043,358View SEC Filing Icon  
7/3/2023Alan H. AuerbachCEOSell60,698$3.31$200,910.386,978,343View SEC Filing Icon  
7/3/2023Alvin F. WongInsiderSell6,938$3.31$22,964.78105,947View SEC Filing Icon  
7/3/2023Maximo F. NouguesCFOSell14,680$3.31$48,590.80144,348View SEC Filing Icon  
6/13/2023Troy Edward WilsonDirectorSell27,000$3.45$93,150.00350View SEC Filing Icon  
6/2/2023Alvin F. WongInsiderSell269$3.45$928.05112,885View SEC Filing Icon  
1/3/2023Alan H. AuerbachCEOSell27,241$4.18$113,867.386,852,638View SEC Filing Icon  
1/3/2023Alvin F. WongInsiderSell3,460$4.18$14,462.8054,553View SEC Filing Icon  
1/3/2023Maximo F. NouguesCFOSell10,499$4.18$43,885.82100,427View SEC Filing Icon  
11/2/2022Alan H. AuerbachCEOSell1,242$2.25$2,794.506,312,949View SEC Filing Icon  
11/2/2022Douglas M. HuntInsiderSell429$2.25$965.2576,004View SEC Filing Icon  
11/2/2022Maximo F. NouguesCFOSell163$2.25$366.75111,085View SEC Filing Icon  
10/3/2022Alan H. AuerbachCEOSell1,260$2.34$2,948.406,314,191View SEC Filing Icon  
10/3/2022Douglas M. HuntInsiderSell435$2.34$1,017.9076,433View SEC Filing Icon  
10/3/2022Maximo F. NouguesCFOSell165$2.34$386.10111,248View SEC Filing Icon  
8/9/2022Michael Patrick MillerDirectorSell25,000$3.55$88,750.0054,858View SEC Filing Icon  
8/2/2022Alan H. AuerbachCEOSell1,247$2.89$3,603.836,316,705View SEC Filing Icon  
8/2/2022Douglas M. HuntInsiderSell429$2.89$1,239.8177,301View SEC Filing Icon  
8/2/2022Maximo F. NouguesCFOSell161$2.89$465.29111,577View SEC Filing Icon  
7/5/2022Alan H. AuerbachCEOSell26,140$2.63$68,748.206,317,952View SEC Filing Icon  
7/5/2022Douglas M. HuntInsiderSell3,753$2.63$9,870.3977,730View SEC Filing Icon  
7/5/2022Maximo F. NouguesCFOSell5,835$2.63$15,346.0564,625View SEC Filing Icon  
6/16/2022Troy Edward WilsonDirectorSell27,858$2.58$71,873.6427,350View SEC Filing Icon  
6/2/2022Alan H. AuerbachCEOSell1,200$1.94$2,328.006,344,092View SEC Filing Icon  
6/2/2022Alvin F. WongInsiderSell587$1.92$1,127.0461,447View SEC Filing Icon  
6/2/2022Maximo F. NouguesCFOSell162$1.92$311.04121,066View SEC Filing Icon  
5/3/2022Alan H. AuerbachCEOSell1,263$2.32$2,930.166,345,292View SEC Filing Icon  
5/3/2022Douglas M. HuntInsiderSell438$2.31$1,011.7881,900View SEC Filing Icon  
5/3/2022Maximo F. NouguesCFOSell165$2.34$386.10121,228View SEC Filing Icon  
4/4/2022Alan H. AuerbachCEOSell1,198$3.08$3,689.846,346,555View SEC Filing Icon  
3/2/2022Alan H. AuerbachCEOSell1,294$2.26$2,924.44View SEC Filing Icon  
3/2/2022Douglas M. HuntInsiderSell446$2.26$1,007.96View SEC Filing Icon  
3/2/2022Maximo F. NouguesCFOSell169$2.26$381.94View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Puma Biotechnology (NASDAQ:PBYI)

61.29% of Puma Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PBYI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Puma Biotechnology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Squarepoint Ops LLC75,929$0.23M0.0%-23.5%0.155%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP181,471$0.55M0.0%+266.2%0.370%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP196,900$0.60M0.0%+22.3%0.401%Search for SEC Filing on Google Icon
2/17/2025State of Wyoming20,426$62K0.0%-72.0%0.042%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC11,853$36K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC79,101$0.24M0.0%+41.4%0.161%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC1,894,126$5.78M0.0%-34.3%3.858%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.10,732$33K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.222,608$0.68M0.0%+287.9%0.453%Search for SEC Filing on Google Icon
2/17/2025Cubist Systematic Strategies LLC32,615$99K0.0%N/A0.066%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE82,339$0.25M0.0%+103.1%0.168%Search for SEC Filing on Google Icon
2/17/2025Bayesian Capital Management LP17,700$54K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets74,301$0.23M0.0%+9.7%0.151%Search for SEC Filing on Google Icon
2/17/2025Acorn Capital Advisors LLC2,450,711$7.48M4.1%N/A4.992%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC22,480$69K0.0%-30.0%0.046%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC35,300$0.11M0.0%-70.1%0.072%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp325,417$0.99M0.0%+2.4%0.663%Search for SEC Filing on Google Icon
2/14/2025Oxford Asset Management LLP23,484$72K0.0%N/A0.048%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD19,083$59K0.0%+42.9%0.039%Search for SEC Filing on Google Icon
2/14/2025Eversept Partners LP996,102$3.04M0.3%-23.0%2.029%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 10,137$31K0.0%+167.7%0.021%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP863,760$2.64M0.0%+24.7%1.760%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP85,580$0.26M0.0%N/A0.174%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC38,845$0.12M0.0%N/A0.079%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd59,674$0.18M0.0%+126.2%0.122%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC88,407$0.27M0.0%+13.3%0.180%Search for SEC Filing on Google Icon
2/13/2025Kennedy Capital Management LLC809,375$2.47M0.1%+36.5%1.649%Search for SEC Filing on Google Icon
2/13/2025LSV Asset Management53,400$0.16M0.0%+75.7%0.109%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC1,755,513$5.35M0.0%-1.0%3.576%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN22,929$70K0.0%+36.5%0.047%Search for SEC Filing on Google Icon
2/13/2025Integrated Quantitative Investments LLC59,866$0.18M0.1%N/A0.122%Search for SEC Filing on Google Icon
2/12/2025O Shaughnessy Asset Management LLC112,571$0.34M0.0%+99.7%0.229%Search for SEC Filing on Google Icon
2/12/2025C2C Wealth Management LLC12,000$37K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.136,897$0.42M0.0%+182.3%0.279%Search for SEC Filing on Google Icon
2/12/2025WINTON GROUP Ltd38,241$0.12M0.0%-87.6%0.078%Search for SEC Filing on Google Icon
2/11/2025Prudential Financial Inc.106,285$0.32M0.0%+5.8%0.217%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC26,567$81K0.0%+23.6%0.054%Search for SEC Filing on Google Icon
2/11/2025Sei Investments Co.311,661$0.95M0.0%+8.0%0.635%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.948,376$2.89M0.0%+8.4%1.932%Search for SEC Filing on Google Icon
2/10/2025Connor Clark & Lunn Investment Management Ltd.487,368$1.49M0.0%+32.3%0.993%Search for SEC Filing on Google Icon
2/4/2025Los Angeles Capital Management LLC285,679$0.87M0.0%+16.3%0.582%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp331,853$1.01M0.0%+19.5%0.676%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers38,291$0.12M0.0%-17.9%0.078%Search for SEC Filing on Google Icon
1/23/2025Gateway Wealth Partners LLC10,200$31K0.0%N/A0.021%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC24,668$75K0.0%+83.9%0.050%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.48,493$0.12M0.0%+169.5%0.099%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.15,967$41K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC26,509$68K0.0%N/A0.054%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC78,021$0.20M0.0%+146.5%0.159%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC917,367$2.34M0.0%-3.4%1.869%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC78,021$0.20M0.0%+146.5%0.159%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd26,384$67K0.0%-45.7%0.054%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC32,129$82K0.0%+103.9%0.065%Search for SEC Filing on Google Icon
11/15/2024State Street Corp601,542$1.53M0.0%+17.0%1.225%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets67,702$0.17M0.0%+2,002.5%0.138%Search for SEC Filing on Google Icon
11/13/2024FMR LLC118,265$0.30M0.0%+27.1%0.241%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP108,129$0.28M0.1%N/A0.220%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd17,366$44K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.117,666$0.30M0.0%-6.8%0.240%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.368,455$0.94M0.0%+3.9%0.751%Search for SEC Filing on Google Icon
11/8/2024Prospera Financial Services Inc168,885$0.43M0.0%+12.9%0.344%Search for SEC Filing on Google Icon
11/6/2024Royce & Associates LP20,165$51K0.0%+71.8%0.041%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.35,097$89K0.0%+111.9%0.072%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP49,494$0.13M0.0%-73.9%0.101%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC245,695$0.63M0.0%N/A0.501%Search for SEC Filing on Google Icon
10/24/2024Patriot Financial Group Insurance Agency LLC19,000$48K0.0%+72.7%0.039%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC13,416$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.3,062,558$9.98M0.5%+8.7%6.349%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company17,765$58K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC3,162,533$10.31M0.0%-4.0%6.448%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC250,000$0.82M0.1%N/A0.510%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC71,391$0.23M0.0%+17.7%0.146%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC1,486,544$4.85M0.9%+10.6%3.082%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP200,085$0.65M0.0%-16.1%0.415%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd48,611$0.16M0.0%-10.2%0.101%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC14,236$46K0.0%-79.7%0.030%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,753,013$5.72M0.0%+1.4%3.634%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP605,977$1.98M0.0%+6.6%1.256%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd300,599$0.98M0.1%+59.7%0.623%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.738,902$2.41M0.0%+98.5%1.532%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC144,792$0.47M0.0%+3.3%0.300%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC1,951,208$6.36M0.0%-0.3%4.045%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.16,565$54K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers50,270$0.16M0.0%+2,309.9%0.104%Search for SEC Filing on Google Icon
8/1/2024Ritholtz Wealth Management33,759$0.11M0.0%-9.6%0.070%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.102,820$0.34M0.0%N/A0.213%Search for SEC Filing on Google Icon
7/26/2024Patriot Financial Group Insurance Agency LLC11,000$36K0.0%-37.5%0.023%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp308,997$1.01M0.0%+63.6%0.641%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.140,205$0.46M0.0%+99.9%0.291%Search for SEC Filing on Google Icon
5/17/2024Athyrium Capital Management LP1,256,411$6.66M9.1%-29.9%2.605%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC49,466$0.26M0.0%+5,129.0%0.103%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC61,991$0.33M0.3%N/A0.129%Search for SEC Filing on Google Icon
5/13/2024O Shaughnessy Asset Management LLC77,081$0.41M0.0%+127.7%0.160%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC1,956,513$10.37M0.0%+2.0%4.056%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.3,491,249$18.50M0.0%-8.2%7.237%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.289,677$1.54M0.0%-0.8%0.600%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC10,740$57K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/6/2024LSV Asset Management30,400$0.16M0.0%-64.9%0.063%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP187,585$0.99M0.1%-28.5%0.389%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.70,145$0.37M0.0%-17.5%0.145%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Puma Biotechnology logo
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Read More on Puma Biotechnology

Today's Range

Now: $2.86
Low: $2.85
High: $2.98

50 Day Range

MA: $3.01
Low: $2.75
High: $3.74

52 Week Range

Now: $2.86
Low: $2.22
High: $7.73

Volume

201,572 shs

Average Volume

452,755 shs

Market Capitalization

$140.40 million

P/E Ratio

5.96

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Puma Biotechnology?

Puma Biotechnology's top insider shareholders include:
  1. Alan H Auerbach (CEO)
  2. Maximo F Nougues (CFO)
  3. Jeffrey Jerome Ludwig (Insider)
  4. Alvin F Wong (Insider)
  5. Michael Patrick Miller (Director)
  6. Troy Edward Wilson (Director)
Learn More about top insider investors at Puma Biotechnology.

Who are the major institutional investors of Puma Biotechnology?

Puma Biotechnology's top institutional investors include:
  1. Acorn Capital Advisors LLC — 4.99%
  2. Millennium Management LLC — 3.86%
  3. Renaissance Technologies LLC — 3.58%
  4. Eversept Partners LP — 2.03%
  5. American Century Companies Inc. — 1.93%
  6. Dimensional Fund Advisors LP — 1.76%
Learn More about top institutional investors of Puma Biotechnology stock.

Which major investors are selling Puma Biotechnology stock?

Within the last quarter, PBYI stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Eversept Partners LP
  3. WINTON GROUP Ltd
  4. Schonfeld Strategic Advisors LLC
  5. State of Wyoming
  6. Squarepoint Ops LLC
  7. Renaissance Technologies LLC
  8. Jane Street Group LLC
During the previous year, company insiders that have sold Puma Biotechnology company stock include:
  1. Alan H Auerbach (CEO)
  2. Maximo F Nougues (CFO)
  3. Jeffrey Jerome Ludwig (Insider)
  4. Alvin F Wong (Insider)
  5. Michael Patrick Miller (Director)
Learn More investors selling Puma Biotechnology stock.

Which major investors are buying Puma Biotechnology stock?

During the previous quarter, PBYI stock was bought by institutional investors including:
  1. Acorn Capital Advisors LLC
  2. Kennedy Capital Management LLC
  3. Dimensional Fund Advisors LP
  4. D. E. Shaw & Co. Inc.
  5. Two Sigma Investments LP
  6. Connor Clark & Lunn Investment Management Ltd.
  7. JPMorgan Chase & Co.
  8. Marshall Wace LLP